Assessing the Drivers and Challenges to Deploying Lean-Green Practices the in Indian Manufacturing Sector

Krishnan, Srijit; Mathiyazhagan, K.; Appolloni, Andrea

doi:10.1007/978-981-16-5551-7_2

Cited by 1 publication

(1 citation statement)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To ensure improved regulatory compliance, Jalundhwala and Londhe (2023) identified a number of enablers for operational excellence in the pharmaceutical sector. Some evidence of lean practices in different regions can be found in many publications such as (Garza-Reyes et al, 2012;Ghosh, 2013;Krishnan et al, 2022;Verma et al, 2022;Citybabu and Yamini, 2022;Hasan et al, 2022).…”

Section: Introductionmentioning

confidence: 99%

Exploring lean manufacturing drivers for enhancing circular economy performance in the pharmaceutical industry: a Bayesian best–worst approach

Salman,

Morshed,

Karim

et al. 2024

IJIEOM

View full text Add to dashboard Cite

PurposeThe imperative to conserve resources and minimize operational expenses has spurred a notable increase in the adoption of lean manufacturing within the context of the circular economy across diverse industries in recent years. However, a notable gap exists in the research landscape, particularly concerning the implementation of lean practices within the pharmaceutical industry to enhance circular economy performance. Addressing this void, this study endeavors to identify and prioritize the pivotal drivers influencing lean manufacturing within the pharmaceutical sector.FindingsThe outcome of this rigorous examination highlights that “Continuous Monitoring Process for Sustainable Lean Implementation,” “Management Involvement for Sustainable Implementation” and “Training and Education” emerge as the most consequential drivers. These factors are deemed crucial for augmenting circular economy performance, underscoring the significance of management engagement, training initiatives and a continuous monitoring process in fostering a closed-loop practice within the pharmaceutical industry.Research limitations/implicationsThe findings contribute valuable insights for decision-makers aiming to adopt lean practices within a circular economy framework. Specifically, by streamlining the process of developing a robust action plan tailored to the unique needs of the pharmaceutical sector, our study provides actionable guidance for enhancing overall sustainability in the manufacturing processes.Originality/valueThis study represents one of the initial efforts to systematically identify and assess the drivers to LM implementation within the pharmaceutical industry, contributing to the emerging body of knowledge in this area.

show abstract